Literature DB >> 11674087

Vancomycin CD and DE Macrocyclization and Atropisomerism Studies.

Dale L. Boger1, Steven L. Castle, Susumu Miyazaki, Jason H. Wu, Richard T. Beresis, Olivier Loiseleur.   

Abstract

Continued studies on the synthesis and atropisomerism of the vancomycin CD and DE ring systems based on aromatic nucleophilic substitution macrocyclization reactions for formation of the biaryl ethers are detailed in efforts that further define substituent effects, explore the impact of protecting groups, and establish the stereochemical integrity of peripheral substituents. These have led to the identification of a previously unrecognized site of epimerization within our original approach to the DE ring system and the introduction of significant improvements in the approach that will find utilization in syntheses of the vancomycin CDE ring system and of the natural product itself. The preparation of a complete set of DE ring system isomers bearing the unnatural stereochemistry at the labile C8, C11, and C14 sites was accomplished for comparison and established that C8 is prone to epimerization to the more stable, unnatural S versus R absolute stereochemistry if it bears an ester, but not a carboxamide, substituent. Additionally, an improved synthesis of the CD ring system, enlisting a C14 carboxamide versus ester substituent, is disclosed and establishes the stereochemical integrity of our prior approach which incorporated a C14 ester. A set of fully functionalized CD and DE ring systems were prepared and include the development of conditions for the final deprotections required for incorporation into efforts on the natural product. The examination of the antimicrobial activity of these key substructures of vancomycin is detailed.

Entities:  

Year:  1999        PMID: 11674087     DOI: 10.1021/jo980880o

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  8 in total

1.  Catalytic site-selective thiocarbonylations and deoxygenations of vancomycin reveal hydroxyl-dependent conformational effects.

Authors:  Brandon S Fowler; Kai M Laemmerhold; Scott J Miller
Journal:  J Am Chem Soc       Date:  2012-05-23       Impact factor: 15.419

Review 2.  Natural Products as Platforms To Overcome Antibiotic Resistance.

Authors:  Sean E Rossiter; Madison H Fletcher; William M Wuest
Journal:  Chem Rev       Date:  2017-09-27       Impact factor: 60.622

3.  Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Authors:  Jian Xie; Akinori Okano; Joshua G Pierce; Robert C James; Simon Stamm; Christine M Crane; Dale L Boger
Journal:  J Am Chem Soc       Date:  2012-01-06       Impact factor: 15.419

4.  Total synthesis and evaluation of [Psi[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.

Authors:  Brendan M Crowley; Dale L Boger
Journal:  J Am Chem Soc       Date:  2006-03-08       Impact factor: 15.419

5.  Total synthesis of complestatin: development of a Pd(0)-mediated indole annulation for macrocyclization.

Authors:  Hiroyuki Shimamura; Steven P Breazzano; Joie Garfunkle; F Scott Kimball; John D Trzupek; Dale L Boger
Journal:  J Am Chem Soc       Date:  2010-06-09       Impact factor: 15.419

Review 6.  Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues.

Authors:  Akinori Okano; Nicholas A Isley; Dale L Boger
Journal:  Chem Rev       Date:  2017-04-24       Impact factor: 60.622

7.  Total synthesis of chloropeptin II (complestatin) and chloropeptin I.

Authors:  Joie Garfunkle; F Scott Kimball; John D Trzupek; Shinobu Takizawa; Hiroyuki Shimamura; Masaki Tomishima; Dale L Boger
Journal:  J Am Chem Soc       Date:  2009-11-11       Impact factor: 15.419

8.  Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2.

Authors:  George R Pettit; Peter D Quistorf; Jeremy A Fry; Delbert L Herald; Ernest Hamel; Jean-Charles Chapuis
Journal:  J Nat Prod       Date:  2009-05-22       Impact factor: 4.050

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.